SubHero Banner
Text

February 2021

Core topics in this month’s edition include:

  • Amondys 45 (casimersen) – new orphan drug approval
  • Breyanzi (lisocabtagene maraleucel) – new orphan drug approval
  • Nulibry (fosdenopterin) – new orphan drug approval

Download PDF

Text